We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.
- Authors
Kubota, Kaoru; Watanabe, Koshiro; Kunitoh, Hideo; Noda, Kazumasa; Ichinose, Yukito; Katakami, Nobuyuki; Sugiura, Takahiko; Kawahara, Masaaki; Yokoyama, Akira; Yokota, Soichiro; Yoneda, Shuichi; Matsui, Kaoru; Kudo, Shinzo; Shibuya, Masahiko; Isobe, Takeshi; Segawa, Yoshihiko; Nishiwaki, Yutaka; Ohashi, Yasuo; Niitani, Hisanobu; Japanese Taxotere Lung Cancer Study Group
- Abstract
Few randomized trials have demonstrated survival benefit of combination chemotherapy involving new agents plus cisplatin compared with classic combination chemotherapy in advanced non-small-cell lung cancer (NSCLC). The primary aim of this study was to test whether docetaxel plus cisplatin (DC) improves survival compared with vindesine plus cisplatin (VdsC) in patients with previously untreated stage IV NSCLC.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Vol 22, Issue 2, p254
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2004.06.114